Patent Number: 8,871,202

Title: Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Abstract: The present invention relates to use of anti-S1P agents, for example, humanized monoclonal antibodies, for prevention and/or treatment of pain, including neuropathic pain, hyperalgesia, allodynia, and chemotherapy-induced pain.

Inventors: Sabbadini; Roger A. (Lakeside, CA)

Assignee: Lpath, Inc.

International Classification: A61K 39/395 (20060101)

Expiration Date: 2018-10-28 0:00:00